Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology

Atif, Muhammad; Azeem, Muhammad; Saqib, Anum; Scahill, Shane

doi:10.1186/s13756-017-0199-7

Antimicrobial Resistance & Infection Control

Table 7 DDDs/1000 hospitalization days of the antimicrobials being prescribed at the BVH and their comparison across the selected wards

From: Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology

Sr. No.	Antimicrobial	Route	WHO DDD	CDU	ENT	Gynecology	M 1	M 2	Nephrology	Orthopedics	S4	Skin	Urology	Total	Mean
1	Amikacin 0.5 g	Parenteral	1 g	---	---	---	---	---	---	1.92	---	---	2.38	4.3	2.15 g
2	Ampicillin 0.5 g	Parenteral	2 g	---	10.51	---	---	---	---	---	---	---	---	10.51	10.51 g
3	Amoxiclav 0.625 g	Oral	1 g	2.48	2.60	---	0.85	2.40	22.20	---	8.13	81.28	---	119.94	17.13 g
4	Amoxiclav 1.2 g	Parenteral	3 g	0.5	3.63	---	6.52	3.39	89.8	---	9.82	209.0	---	322.66	46.09 g
5	Cefoperazone + Sulbactam 1 g	Parenteral	4 g	---	---	---	---	---	---	3.33	---	---	16.13	19.46	9.73 g
6	Cefotaxime 0.25 g	Parenteral	4 g	0.28	2.62	1.62	---	---	1.74	---	0.03	---	0.32	6.61	1.1 g
7	Cefotaxime 1 g	Parenteral	4 g	1.93	17.42	16.61	---	---	20.6	---	0.32	---	2.68	59.56	9.92 g
8	Ceftriaxone 0.25 g	Parenteral	2 g	3.11	0.23	---	1.64	0.99	---	3.10	3.18	2.68	1.27	16.2	2.02 g
9	Ceftriaxone 1 g	Parenteral	2 g	18.4	7.38	---	9.78	11.84	---	14.61	28.27	37.24	5.82	133.34	16.7 g
10	Ciprofloxacin 0.4 g	Parenteral	0.5 g	9.37	14.54	---	3.2	2.36	45.95	3.89	1.63	56.56	30.19	167.69	18.6 g
11	Ciprofloxacin 0.5 g	Oral	1 g	1.67	3.40	---	0.73	0.57	18.14	1.02	0.37	22.72	12.78	61.4	6.82 g
12	Clarithromycin 0.25 g	Oral	0.5 g	3.55	---	---	---	0.16	---	---	---	---	---	3.71	1.85 g
13	Clarithromycin 0.5 g	Oral	0.5 g	2.30	---	---	0.02	---	---	---	---	---	---	2.32	1.16 g
14	Clarithromycin 0.5 g	Parenteral	1 g	2.92	---	---	0.13	0.04	---	---	---	---	---	3.09	1.03 g
15	Gentamicin 0.12 g	Parenteral	0.24 g	---	2.74	---	---	---	---	---	1.67	---	---	4.41	2.2 g
16	Metronidazole 0.4 g	Oral	2 g	1.21	1.13	4.43	0.5	0.47	2.56	0.20	2.49	4.29	0.1	17.38	1.73 g
17	Metronidazole 1 g	Parenteral	1.5 g	2.65	6.56	44.74	4.7	2.95	13.60	1.87	14.13	15.15	1.05	107.4	10.74 g
18	Moxifloxacin0.4 g	Parenteral	0.4 g	2.30	---	---	0.82	0.24	33.25	---	---	---	1.05	37.66	7.53 g
19	Moxifloxacin 0.4 g	Oral	0.4 g	1.88	---	---	0.54	---	18.14	---	---	---	0.53	21.09	5.28 g
20	Vancomycin 0.5 g	Parenteral	2 g	---	---	---	1.05	1.35	7.93	---	---	---	---	10.33	3.5 g

WHO World Health Organization, DDD Defined daily dose, CDU Chest Disease Unit, ENT Ear Nose Throat, M1 Medical 1, M2 Medical 2, S4 Surgical 4

Back to article page

ISSN: 2047-2994

Contact us

General enquiries: journalsubmissions@springernature.com